Viewing Study NCT06810492


Ignite Creation Date: 2025-12-24 @ 3:19 PM
Ignite Modification Date: 2026-02-05 @ 4:46 AM
Study NCT ID: NCT06810492
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-03-17
First Post: 2024-12-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Efficacy and Safety of CDK4/6 Inhibitors in Combination with Endocrine Therapy in the Neoadjuvant Treatment
Sponsor: Hongmei Zheng, PhD
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer Stage III View
None Breast Cancer Stage II View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hormone receptor (HR) positive View
None HER2 negative View
None neoadjuvant treatment View
None CDK4/6 inhibitors View